Xinjiang Ruinuo builds 3,500 t/a nucleotide capacity
Xinjiang Ruinuo Biotechnology Co., Ltd. (Xinjiang Ruinuo) finished the first phase of its "8,000 t/a nucleoside pharmaceutical ingredients or intermediates project", according to the monitoring report on the inspection and acceptance publicised on 27...
Corn Products China News 202403